CAPR Stock UPDATES Capricor Therapeutics Inc. (CAPR) 4.3000 08/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capricor Therapeutics Inc. (CAPR) 4.3000 $CAPR

Capricor Therapeutics Reports Second Quarter 2014 Financial & Business Highlights
GlobeNewswire - Wed Aug 13, 9:19AM CDT
Reports Encouraging Results From Phase I of the ALLSTAR Clinical Trial and Signed Exclusive License With Cedars-Sinai Medical Center for Exosomes IP Portfolio

Capricor Therapeutics to Hold Second Quarter 2014 Business Update Conference Call on August 13, 2014 at 4:30 p.m. Eastern Time
GlobeNewswire - Mon Aug 04, 7:27AM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics to prevent and treat heart disease, today announced that Company management will hold a conference call to discuss second quarter 2014 business highlights on Wednesday, August 13, 2014, at 4:30 p.m. ET.

Capricor Announces Encouraging Results From Phase I ALLSTAR Trial; Phase II Trial Underway
GlobeNewswire - Wed Jul 16, 6:59AM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, announced today encouraging analysis of the completion of its MRI data at the six-month time point from Capricor's Phase I ALLSTAR trial.

Capricor Therapeutics to Present at the First Regenerative Medicine Forum at BIO International Convention
GlobeNewswire - Mon Jun 23, 8:03AM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that Dr. Linda Marbán, President and CEO, will present during a panel at the first, all-day Regenerative Medicine Forum organized by the California Institute for Regenerative Medicine (CIRM), in association with the Alliance for Regenerative Medicine (ARM) and the International Society for Stem Cell Research (ISSCR). The Regenerative Medicine Forum will take place on Wednesday, June 25, 2014 during the BIO International Convention being held June 23-26, 2014 in San Diego, California.

Capricor Therapeutics Speaks at Panel on Regulation of Stem Cell-Derived Therapeutic Products at DIA 2014 50th Annual Meeting
GlobeNewswire - Thu Jun 19, 12:28PM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced that Dr. Rachel Ruckdeschel Smith, Ph.D., Vice President of Research and Development at Capricor, participated in a panel discussion on the regulation of therapeutic products derived from human stem cells at the DIA 2014 50 Annual Meeting, being held June 15-19, 2014 in San Diego, California.

Capricor Therapeutics to Present ALLSTAR Phase I Trial Data at ACC Annual Meeting 2014
GlobeNewswire - Fri Mar 28, 12:42PM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR), a biotechnology company focused on developing novel therapeutics to prevent and treat heart disease, today announced Co-founder and Scientific Advisory Board Chairman, Dr. Eduardo Marbán, M.D., Ph.D., will present at the American College of Cardiology 63 Annual Scientific Session and Expo, taking place March 29-31, 2014 in Washington, DC. Dr. Marbán's presentation will highlight positive data demonstrating that the Phase I portion of the Company's ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR) Phase I/II trial met its primary endpoint of safety.

Capricor Therapeutics to Present at Two Upcoming Investor Conferences
GlobeNewswire - Mon Mar 10, 1:11PM CDT
Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that Chief Executive Officer Dr. Linda Marbán is scheduled to present at the 26 Annual ROTH Conference, being held March 9-12, 2014 in Dana Point, Calif., and the Alliance for Regenerative Medicine's 2 Annual Regen Med Investor Day on March 26, 2014 in New York, N.Y.

Capricor Therapeutics and Janssen Biotech, Inc. Enter Into Collaboration Agreement and Exclusive License Option
GlobeNewswire - Mon Jan 06, 7:30AM CST
Capricor Therapeutics, Inc. (OTCBB:CAPR) today announced that it has executed a collaboration agreement and exclusive license option with Janssen Biotech, Inc. (Janssen). Under the terms of the agreement, Capricor and Janssen agreed to collaborate on the development of Capricor's cell therapy program for cardiovascular applications, including its lead product, CAP-1002. CAP-1002 is an allogeneic cardiosphere-derived cell (CDC) therapeutic under evaluation in patients who have suffered a large myocardial infarction. Pursuant to the agreement, Capricor and Janssen will collaborate on elements of cell manufacturing development. Capricor will contribute to the costs of the manufacturing collaboration, and will receive an upfront payment of $12.5 million from Janssen.

Capricor Therapeutics Announces Ticker Symbol Change to CAPR
Business Wire - Fri Dec 20, 5:00AM CST
Capricor Therapeutics, Inc. (OTCBB: CAPR), a diversified heart failure biotechnology company, today announced that, effective today, the Company's common stock commences trading on the OTC Markets under the new symbol "CAPR." The previous trading symbol was "NLTXD." The ticker symbol change follows the recently completed merger between Capricor, Inc. and Nile Therapeutics, Inc.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 77

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading
Decoding the Insurance Agent Hunt in Hot Springs

Updated Category News Views 35

Look Beyond Just Rates When Selecting Your Agent When it comes to picking the right insurance agent in the charming enclave of Hot Springs, AR, it's not just about snagging the lowest rate. Victoria Payne, a seasoned pro from the Victoria Payne Agency, drills down on what actually counts in the HelloNation article she's featured in. It's about more than dollars and cents;...

Continue Reading
GAC Dominates with 8 Awards in Cutting-Edge Tech

Updated Category News Views 97

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 96

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 84

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading
LeanDNA's APEX Awards Spotlight Supply Chain Innovators

Updated Category News Views 66

Shaking Things Up in Supply Chain with APEX Awards LeanDNA has just dropped their second annual APEX Awards on us, sending ripples through the world of supply chain management. The big reveal happened at the LeanDNA Manufacturing Excellence Summit in Austin, celebrating those who are pushing the envelope in logistics using cutting-edge technology. Award Categories and...

Continue Reading
HIMS Faces Class Action Over Alleged Privacy Violations

Updated Category News Views 66

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Continue Reading
Excellence Award Celebrates Medicilon-Revolution Partnership

Updated Category News Views 27

Breaking the 'Undruggable' Myth Out there in the trenches of drug discovery, this Medicilon and Revolution Medicines partnership has been stirring up some waves. Now, I ain't talking about your daily Wall Street hubbub, but a three-year grind that's led to something seriously noteworthy: turning the so-called 'undruggable' KRAS target into a real game-changer. Pan-KRAS...

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 121

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Trade Cases on Pizza Box Imports Set Industry Ablaze

Updated Category News Views 66

U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...

Continue Reading

Top 5 Most Recently Viewed Articles

Amendments Approved by Baltic Horizon Fund Bondholders

Updated Category News Views 192

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Continue Reading
Sagimet Biosciences Shares Exciting First Quarter Highlights

Updated Category News Views 177

Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...

Continue Reading
Important Class Action for Lilium N.V. Shareholders to Join

Updated Category News Views 107

Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....

Continue Reading
Intellia Launches Pivotal Phase 3 Trial for NTLA-2002

Updated Category News Views 84

Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...

Continue Reading
Margot Black Unveils New Book: Transform Your Dreams Now

Updated Category News Views 120

Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...

Continue Reading